BioNTech SEChange company Symbol lookupSelect an option...BNTX BioNTech SEITRI Itron IncLTTTX MFS Lifetime 2025 Fund Class R3HLI Houlihan Lokey IncKICK Master Glazier's Karate International IncVIRT Virtu Financial IncFB Facebook IncED Consolidated Edison IncCLS Celestica IncHNHAF Hon Hai Precision Industry Co LtdGo
Based in Germany
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
American Depositary Receipt (ADR) Fee
ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| November 10, 2020 | Q3 2020 Earnings Release | -$1.01 | -$0.5728 to -$0.1959 | -$0.1457 |
| August 11, 2020 | Q2 2020 Earnings Release | -$0.4159 | -$0.5473 to $0.1018 | -- |
| July 2, 2020 | Q1 2020 Earnings Release | -$0.2651 | -$0.2982 to -$0.1568 | -- |
| March 31, 2020 | Q4 2019 Earnings Release | -$0.287 | -$0.2373 to -$0.1755 | -- |
Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.
, , , Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.